2552 — Hua Medicine Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$1.15bn
- -HK$25.28m
- CNY76.61m
- 28
- 31
- 25
- 13
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -425 | -393 | -326 | -204 | -211 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 51.3 | 81.4 | 40.3 | -31.3 | -66.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 21.5 | 272 | -19.2 | -27.1 | 1,131 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -342 | -20.9 | -273 | -230 | 889 |
Capital Expenditures | -10.3 | -25.7 | -66.9 | -27.5 | -9.84 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.778 | 11.6 | -1.33 | 22.7 | 17.9 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.52 | -14.1 | -68.2 | -4.75 | 8.08 |
Financing Cash Flow Items | 0 | — | — | -0.088 | -5.08 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.24 | -7.26 | -6.13 | 21.5 | 69.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -338 | -73.5 | -357 | -185 | 970 |